index - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques

Dernières publications

Chiffres clés

59 Publications avec texte intégral

Open Access

47 %

Mots clés

Gender Ectopic germinal centers Glucocorticoids B cells Etiology Myasthenia Gravis MG Autoimmunity LMNA PBMC MG patients Germinal center Thymectomy Chemokine CXCL13-CXCR5 CD31 Germinal centers Immunology and Microbiology Section Acides nucléiques endogènes Gd T cells Cellules th17 Lamin A/C nuclei Interferonopathy Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Acetylcholine receptors Immune response Experimental autoimmune myasthenia gravis EAMG Interferon-β Interferon type I Early-onset myasthenia gravis Auto-immunité Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Conduction disease Exercise Experimental models Puberty Interleukin 23 Interferon IFN Antimir-150 Cell-cell communication Myoblasts Innate immunity Centres germinatifs ectopiques Anticorps monoclonal Acetylcholine receptor Interferon de type I Chronic inflammation Th17 cells BAFF Follicular hyperplasia Complete Freund's adjuvant Clinical cell transplantation FMR1 Thymic epithelial cells Disease susceptibility Chronicity Immunity CTCF Experimental autoimmune myasthenia gravis Fragile X syndromes Thymoma Myasthénie grave Thymus Interleukine-23 AChR antibodies COX2 Animal models Chemokines COVID-19 Adaptive immunity DICER Age Il-23 Acetylcholine receptor antibodies Experimental mouse models Autoimmune disease Human myoblasts Inflammatory cytokines Assay comparison Ferrites Myasthenia gravis Endogenous nucleic acids Immunotherapy Heart failure Transcriptome Cardiomyopathy Genetics Interferon type-I Cytokines Immune regulation Myasthenia Gravis Quality of life M3243AG Inflammation Neuromuscular junction Autoimmune diseases CCL21 Interferon Genetic associations Long-term follow-up Interféron de type I